New study aims to crack the code on drug sequencing for advanced breast cancer
Disease control
Not yet recruiting
This study looks at 40 people with a common type of advanced breast cancer (HR+/HER2-) that has stopped responding to standard hormone therapy. Researchers want to find the best order to give two powerful drugs, called ADCs, to control the cancer longer and with fewer side effect…
Phase: PHASE4 • Sponsor: Yan Xue • Aim: Disease control
Last updated May 01, 2026 15:58 UTC